Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
about
Rituximab: mechanism of actionEnhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scid mice.Mechanisms of action of therapeutic antibodies for cancerRituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.Phase I trial examining addition of gemcitabine to CHOP in intermediate grade NHL.Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma.Empowering targeted therapy: lessons from rituximab.Current treatment options in follicular lymphoma: science and bias.The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma.Rituximab for the treatment of follicular lymphoma.A natural compound, methyl angolensate, induces mitochondrial pathway of apoptosis in Daudi cells.Concurrent administration of granulocyte colony-stimulating factor or granulocyte-monocyte colony-stimulating factor enhances the biological activity of rituximab in a severe combined immunodeficiency mouse lymphoma model.Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics.Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway.The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
P2860
Q24607358-F3565120-F5E7-4F16-8F44-8B2BD186ED2CQ24813078-5AC2A67A-8B02-49DC-9A24-0817802E662BQ28385366-C3FDC1A7-8CF0-4524-A8B7-68B482A410FAQ33364319-FA41FB6F-F3F9-467E-8797-ABD3BF8449DFQ33365711-90EA31D4-2B74-4298-9F01-06FA75CB6B9FQ33396261-EBBC3CEC-E4BC-4D1E-8656-A27B1970A888Q33402203-3906B20A-4DBD-4441-A582-F64C59C223C8Q35835795-1ABC4D12-CD68-4D83-9B68-5107133D485DQ36966780-627445B5-3DF6-426F-AA5B-319BE979FEF1Q37717652-9C3E2356-C3D8-4028-B4BC-859195796406Q38530254-81E29DC0-D193-485E-AAF0-D08DEBD4FDE6Q39360775-CE87165A-8227-4F01-916B-2171CD862086Q39737535-855593F4-49A5-4A5E-93DF-D2781F7489C0Q40355709-64205516-5B7E-4E32-9FE3-A36CBE64CE7AQ40392451-431CB798-E01A-4DD5-89D4-ADABA2B1E1B3Q43814680-08E70848-EE51-40B1-AC7F-6413764ABF92Q50504287-DA6C4E2F-4B2A-48F8-8475-115D2494487AQ53618227-56FE712D-8B2C-4EDD-AA93-0ADB4C856C9D
P2860
Rituximab-mediated sensitization of B-non-Hodgkin's lymphoma (NHL) to cytotoxicity induced by paclitaxel, gemcitabine, and vinorelbine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@en
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@nl
type
label
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@en
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@nl
prefLabel
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@en
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@nl
P2093
P1476
Rituximab-mediated sensitizati ...... gemcitabine, and vinorelbine.
@en
P2093
Ali R Jazirehi
Benjamin Bonavida
Christos Emmanouilides
P304
P356
10.1089/108497802320970226
P577
2002-12-01T00:00:00Z